Depression epidemiology and its treatment evolution.

Robert M A Hirschfeld

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Approximately 1 in 5 US adults have at least one episode of major depression in their lifetime. Of those who do, the majority will relapse over the long term and many will have psychosocial disabilities and reduced functioning. Over the past century, a range of medications have been developed to treat depression, although some effective medications have been superseded by newer treatments with an improved safety and tolerability profile. A reconsideration of some older medications is warranted until agents with truly novel mechanisms of action and good safety and tolerability profiles are available.

Original languageEnglish (US)
JournalThe Journal of clinical psychiatry
Volume73
Issue number10
StatePublished - Oct 2012

Fingerprint

Epidemiology
Safety
Recurrence

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Depression epidemiology and its treatment evolution. / Hirschfeld, Robert M A.

In: The Journal of clinical psychiatry, Vol. 73, No. 10, 10.2012.

Research output: Contribution to journalArticle

@article{3cd67f3f8a6e4a74b19095426f5da154,
title = "Depression epidemiology and its treatment evolution.",
abstract = "Approximately 1 in 5 US adults have at least one episode of major depression in their lifetime. Of those who do, the majority will relapse over the long term and many will have psychosocial disabilities and reduced functioning. Over the past century, a range of medications have been developed to treat depression, although some effective medications have been superseded by newer treatments with an improved safety and tolerability profile. A reconsideration of some older medications is warranted until agents with truly novel mechanisms of action and good safety and tolerability profiles are available.",
author = "Hirschfeld, {Robert M A}",
year = "2012",
month = "10",
language = "English (US)",
volume = "73",
journal = "Journal of Clinical Psychiatry",
issn = "0160-6689",
publisher = "Physicians Postgraduate Press Inc.",
number = "10",

}

TY - JOUR

T1 - Depression epidemiology and its treatment evolution.

AU - Hirschfeld, Robert M A

PY - 2012/10

Y1 - 2012/10

N2 - Approximately 1 in 5 US adults have at least one episode of major depression in their lifetime. Of those who do, the majority will relapse over the long term and many will have psychosocial disabilities and reduced functioning. Over the past century, a range of medications have been developed to treat depression, although some effective medications have been superseded by newer treatments with an improved safety and tolerability profile. A reconsideration of some older medications is warranted until agents with truly novel mechanisms of action and good safety and tolerability profiles are available.

AB - Approximately 1 in 5 US adults have at least one episode of major depression in their lifetime. Of those who do, the majority will relapse over the long term and many will have psychosocial disabilities and reduced functioning. Over the past century, a range of medications have been developed to treat depression, although some effective medications have been superseded by newer treatments with an improved safety and tolerability profile. A reconsideration of some older medications is warranted until agents with truly novel mechanisms of action and good safety and tolerability profiles are available.

UR - http://www.scopus.com/inward/record.url?scp=84891707121&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891707121&partnerID=8YFLogxK

M3 - Article

VL - 73

JO - Journal of Clinical Psychiatry

JF - Journal of Clinical Psychiatry

SN - 0160-6689

IS - 10

ER -